Intragastric prosthesis for the treatment of morbid obesity

• US 6,755,869 B2
• Filed: 01/25/2002
• Issued: 06/29/2004
• Est. Priority Date: 11/09/2001
• Status: Expired due to Term

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Corporation
• Inventors: Geitz, Kurt
• Primary Examiner(s): McDermott, Corrine
• Assistant Examiner(s): Matthews, William H.
• Application Number:
  US10/057,469
• Publication Number:
  US 20030109935A1
• Time in Patent Office: 886 Days
• Field of Search: 623/23.64, 623/23.65, 623/23.67, 623/23.7, 623/23.75, 604/96.01
• US Class Current: 623/23.65
• CPC Class Codes: A61B 17/0469 Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable or resorptive
• CPC Class Codes: A61B 2017/00867 shape memory effect
• CPC Class Codes: A61F 2/0036 implantable A61F2/0018 takes precedence
• CPC Class Codes: A61F 5/0036 Intragastrical devices

Abstract

A porous weave of bioabsorbable filaments having an open mesh configuration is formed into an oblate shape having dimensions greater than the esophageal opening and gastric outlet of a stomach. The resulting prosthesis is deployed in the stomach and is of a size to be retained in the proximate portion thereof for exerting pressure on the upper fundus. The prosthesis limits the amount of food that may be held within the stomach, and exerts pressure on the fundus to create a sensation of being full, resulting in weight loss.

Claims

1. An intra-gastric prosthesis comprising an empty porous oblate body formed of a weave of flexible, resilient filaments and sized for reception in a stomach, the size of the oblate body, when deployed in a stomach, being greater than the esophageal opening and the gastric outlet for retention in the stomach, the body being formed of a generally cylindrical stent of the filaments with opposite ends of the stent reverted and secured together.

2. The prosthesis defined in claim 1, in which the filaments are bioabsorbable, so that the prosthesis will pass from a stomach without surgical intervention after an approximately predetermined period.

3. The prosthesis defined in claim 2, in which the approximately predetermined period is 3 months to 2 years.

4. The prosthesis defined in claim 3, in which the approximately predetermined period is about six months.

5. The prosthesis defined in claim 1, in which the filaments form a body having an open area of at least 80%.

6. The prosthesis defined in claim 5, in which the filaments form a body having an open area of at least 90%.

7. The prosthesis defined in claim 1, in which the body is sized for reception in the proximate portion of the stomach adjacent to the fundus for applying pressure to the fundus.

8. The prosthesis defined in claim 1, in which the body is formed of filaments coated or impregnated with a medical treating agent selected from the group consisting of appetite suppressants and agents to decrease the likelihood of gastric problems.

9. The prosthesis defined in claim 1, in which the body is compressible to a generally cylindrical shape having a diameter of no more than out 2 cm.

10. The prosthesis defined in claim 9, and mechanism for deploying the body in a stomach, such mechanism including a loading member for receiving the body in compressed condition, an advancing member for moving the loading member along the esophagus, and a deployment mechanism for ejecting the body into the stomach whereby the body expands due to memory characteristics of the filaments.